🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has taken down violative content and prohibited related hashtags and search suggestions. The organization said it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, positive reviews and step-by-step guides for mixing or administering at residence.

After moments of entering one group, a vendor posted contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Within these communities, messages show dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose patients to possibly serious medical dangers”.